Randomized controlled trial to evaluate flush and reperfusion techniques in liver transplantation

被引:42
|
作者
Millis, JM
Melinek, J
Csete, M
Imagawa, DK
Olthoff, KM
Neelankanta, G
Braunfeld, MYC
Sopher, MJ
Chan, SM
Pregler, JL
Yersiz, H
Busuttil, AA
Shackleton, CR
Shaked, A
Busuttil, RW
机构
[1] UNIV CALIF LOS ANGELES,MED CTR,DUMONT UCLA TRANSPLANT PROGRAM,LOS ANGELES,CA 90024
[2] UNIV CALIF LOS ANGELES,SCH MED,DEPT ANESTHESIA,LOS ANGELES,CA 90024
关键词
D O I
10.1097/00007890-199702150-00012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine the impact of different flush and reperfusion techniques on postreperfusion syndrome (PRS) and postoperative graft function, 100 transplants were randomly assigned into four groups as follows: group 1 (n=31), portal vein flush, no vena caval venting; group 2 (n=21), hepatic arterial flush, no vena caval venting; group 3 (n=29), portal vein flush with vena caval venting; and group 4 (n=19), hepatic artery flush with vena caval venting. Donor and recipient characteristics were similar. Extensive intraoperative and postoperative monitoring was performed and measurements were documented immediately before reperfusion and at 1, 5, 15, and 30 min after reperfusion. PRS was defined by three criteria: mean arterial pressure (MAP) <60 mmHg at 1 min after reperfusion, MAP<60 mmHg at 5 min after reperfusion, and a decrease of 30% or more for the MAP percent area under the curve during the initial 5 min after reperfusion (%AUC), Using these definitions, the overall incidence of PRS was 21%, 8%, and 43%, respectively. Group 1 was the most hemodynamically stable; the incidence of PRS in group 1 was 2/31 (7%) at 1 min and 8/31 (25%) using %AUC criteria compared with 7/21 (33%) at 1 min and 12/21 (51%) using %AUC criteria for group 2 (P<0.05). The patients in groups 3 and 4 (vena caval venting) demonstrated smaller percentage increases in serum potassium levels (as determined by %AUC; 4.3+/-6.8 and 0.3+/-5.4, vs. 15.1+/-8.1 for group 1 and 22.9+/-8.2 for group 2). The difference between group 4 and group 2 was statistically significant (P<0.05). The increases in serum potassium did not translate into increased cardiac or hemodynamic instability. Combining all data obtained over the first 30 min after reperfusion, there was no statistically significant difference in hemodynamic or biochemical changes noted among the four groups. Postoperative liver function was similar among the four groups. We conclude that portal vein flush without vena caval venting provided a lower incidence of PRS than any other technique. Vena caval venting decreased the release of potassium into the circulation. Postoperative graft function was not significantly affected by flush and reperfusion techniques.
引用
收藏
页码:397 / 403
页数:7
相关论文
共 50 条
  • [1] RANDOMIZED PROSPECTIVE TRIAL TO EVALUATE FLUSH AND REPERFUSION TECHNIQUES IN LIVER-TRANSPLANTATION
    MILLIS, JM
    MELINEK, J
    IMAGAWA, DK
    OLTHOFF, KM
    CSETE, M
    NEELAKANTA, G
    BRAUNFELD, M
    SOPHER, M
    CHAN, S
    PREGLER, J
    YERSIZ, H
    TAMURA, K
    SHACKLETON, C
    SHAKED, A
    BUSUTTIL, RW
    [J]. HEPATOLOGY, 1994, 20 (04) : A194 - A194
  • [2] Effect of intraportal infusion of tacrolimus on ischaemic reperfusion injury in orthotopic liver transplantation: a randomized controlled trial
    Kristo, Ivan
    Wilflingseder, Julia
    Kainz, Alexander
    Marschalek, Julian
    Wekerle, Thomas
    Muehlbacher, Ferdinand
    Oberbauer, Rainer
    Bodingbauer, Martin
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 (09) : 912 - 919
  • [3] Techniques of flushing and reperfusion for liver transplantation
    Gurusamy, Kurinchi Selvan
    Naik, Prashant
    Abu-Amara, Mahmoud
    Fuller, Barry
    Davidson, Brian R.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (03):
  • [4] Oxygen Persufflation in Liver Transplantation Results of a Randomized Controlled Trial
    Gallinat, Anja
    Hoyer, Dieter Paul
    Sotiropoulos, Georgios
    Treckmann, Juergen
    Benkoe, Tamas
    Belker, Jennifer
    Saner, Fuat
    Paul, Andreas
    Minor, Thomas
    [J]. BIOENGINEERING-BASEL, 2019, 6 (02):
  • [5] Anesthetic Conditioning in Liver Transplantation: A multicenter randomized controlled trial
    Kajdi, Marie-Elisabeth
    Bonvini, John M.
    Schadde, Erik
    Figueira, Estela R. R.
    Filho, Joel A. Rocha
    Reyntjens, Koen
    Puhan, Milo A.
    Clavien, Pierre-Alain
    Breitenstein, Stefan
    Beck-Schimmer, Beatrice
    [J]. SWISS MEDICAL WEEKLY, 2013, 143 : 2S - 2S
  • [6] A Randomized Controlled Trial To Evaluate the Effect of Glycemic Control on Renal Transplantation Outcomes
    Hermayer, Kathie L.
    Egidi, Maria F.
    Finch, Nancy J.
    Baliga, Prabhakar K.
    Lin, Angello
    Kettinger, Lindsey D.
    Carter, Rickey
    [J]. DIABETES, 2011, 60 : A47 - A47
  • [7] A Randomized Controlled Trial to Evaluate the Effect of Glycemic Control on Renal Transplantation Outcomes
    Hermayer, Kathie L.
    Egidi, Maria F.
    Finch, Nancy J.
    Baliga, Prabhakar
    Lin, Angello
    Kettinger, Lindsey
    Biggins, Shari
    Carter, Rickey E.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (12): : 4399 - 4406
  • [8] Conditioning With Sevoflurane in Liver Transplantation: Results of a Multicenter Randomized Controlled Trial
    Beck-Schimmer, Beatrice
    Bonvini, John M.
    Schadde, Erik
    Dutkowski, Philipp
    Oberkofler, Christian E.
    Lesurtel, Mickael
    DeOliveira, Michelle L.
    Figueira, Estela R. R.
    Rocha Filho, Joel A.
    Costa Auler, Jose Otavio, Jr.
    D'Albuquerque, Luiz A. C.
    Reyntjens, Koen
    Wouters, Patrick
    Rogiers, Xavier
    Debaerdemaeker, Luc
    Ganter, Michael T.
    Weber, Achim
    Puhan, Milo A.
    Clavien, Pierre-Alain
    Breitenstein, Stefan
    [J]. TRANSPLANTATION, 2015, 99 (08) : 1606 - 1612
  • [9] Outcomes with Intensive Glycemic Control in Liver Transplantation: A Randomized Controlled Trial
    Desai, Kaniksha
    Gandhi, Gunjan
    Shoraka, Ali
    Keaveny, Andrew
    Hellinger, Walter
    Meek, Shon
    [J]. DIABETES, 2015, 64 : A31 - A31
  • [10] Administration of prostacyclin after liver transplantation:: a placebo controlled randomized trial
    Neumann, UP
    Kaisers, U
    Langrehr, JM
    Glanemann, M
    Müller, AR
    Lang, M
    Jörres, A
    Settmacher, U
    Bechstein, WO
    Neuhaus, P
    [J]. CLINICAL TRANSPLANTATION, 2000, 14 (01) : 70 - 74